Windtree Therapeutics, Inc.
Windtree Therapeutics, Inc. (WINT) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
wint · stock forecast · 5 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Buy
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.01
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.01 | ↓ 5.00% |
1-day model range: $0.01–$0.01. Peak: $0.01 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · WINT · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-12-04 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2021-06-04 | Oppenheimer | Maintains | Outperform→Outperform |
| 2020-11-25 | H.C. Wainwright | Maintains | Buy→Buy |
| 2020-11-25 | Ladenburg Thalmann | Maintains | Buy→Buy |
| 2020-06-26 | Ladenburg Thalmann | Maintains | Buy→Buy |
| 2017-06-30 | Stifel Nicolaus | Downgrade ↓ | Buy→Hold |
| 2016-04-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2016-04-22 | H.C. Wainwright | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Windtree Therapeutics, Inc. (WINT) stock. Of the recent 8 rating actions, 0 were upgrades and 1 were downgrades. 5 analysts currently cover WINT.
Analyst Recommendation Trends
WINT analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2M
↓ 83.9% YoY
Revenue Next Year
$12M
↑ 510.0% YoY
EPS This Year
$-173.00
EPS Next Year
$-486.50
↑ 181.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast WINT EPS of $-173.00 for the current fiscal year, based on estimates from 1 analysts. The WINT revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The WINT stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus WINT price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The WINT short-term stock prediction for tomorrow is $0.01 (-5.00%).
Windtree Therapeutics, Inc. trades on OTC under the ticker WINT. The WINT stock outlook for 2027 is broadly positive, supported by a Buy consensus among 60% of covering analysts.
Frequently asked questions
WINT forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month WINT price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $0.01.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.